LABMED Ships 65 Mil + Medical Masks 38 Mil Virus Transport Medium Kits Internationally

LBMED, a Singapore based company, reported today that they have shipped over 65 million masks worldwide. The company specializes in the manufacture of disposable civil mask, medical mask, surgical mask, KN95-FFP2 mask and other medical instruments.

LABMED is currently supplying these much-needed masks and medical devices to Singapore, the US State of Hawaii, the UK, Italy, Germany, India and South Africa.

LABMED has also shipped 38 million VTM (Virus Transport Medium) kits worldwide. These VTMs are a crucial part of the battle against Covid-19, as they are coupled with the nasal swab kits, and they hold the completed swabs that will be sent to laboratories for testing.

The demand for VTM nasal swabs kits and saliva collection kit is expected to rise with the current situation with most countries going through community testing, while the global face mask market is expected to register phenomenal growth by the end of 2020,” says LABMED’s Regional Managing Director, Wilson.

The prominence that LABMED plays in the fight against the Covid-19 pandemic has also guided how it gives back to the communities that are affected by this international crisis.

“As governments, NGOs and healthcare agencies respond to this pandemic, we thought about how to give back to our community.  Fortunately, we are in a good position to offer assistance, and we actively donate and contribute to the less fortunate so they are also taken care of during tough times like these when their financials are impacted,” shares Regional Managing Director, Wilson.

SourceLABMED

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”